Adeona Announces Positive Alzheimer's Subgroup Analysis
Ann Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) Thursday announced positive findings based on further analyses from the clinical study evaluating its product reaZin along with near-term plans for its Alzheimer's disease program.